MAPKAPK3

MAPKAPK3 (MK3/3pK) is a stress- and mitogen-responsive serine/threonine kinase that integrates signals from all three major MAPK cascades—ERK, p38, and JNK—to regulate chromatin remodeling, autophagy, inflammatory cytokine production, NF-κB signaling, and apoptosis (PMID:8943323, PMID:25693418, PMID:17030606, PMID:21586572). Activated predominantly by p38α via proline-directed phosphorylation, MK3 forms a stabilizing complex with p38α and cooperates with its paralog MK2 to phosphorylate substrates including Beclin 1 (S90, promoting starvation-induced autophagy), the Polycomb protein Bmi1 (causing PRC1/PRC2 dissociation from chromatin and de-repression of the INK4A/CDKN2A tumor-suppressor locus), and tristetraprolin (TTP, regulating TNF mRNA stability) (PMID:25693418, PMID:15563468, PMID:25853770, PMID:20599781). MK3 also modulates NF-κB signaling by stabilizing IκBβ and thereby restraining p65 nuclear translocation and IFNβ expression in macrophages (PMID:21586572, PMID:31363109). A heterozygous missense mutation (p.Leu173Pro) in MAPKAPK3 causes retinal dystrophy, with the mutant protein mislocalizing from the nucleus to the cytoplasm and Mapkapk3-knockout mice displaying Bruch's membrane abnormalities (PMID:26744326).

1. 1996 High

   Identification of MAPKAPK3 as a novel kinase activated by all three MAPK cascades established it as a unique convergence point for mitogenic and stress signaling.

   Evidence cDNA cloning, in vitro kinase assays with recombinant ERK/p38/JNK, cotransfection in HEK293 and HL60 cells with pharmacological inhibition

   PMID:8622688 PMID:8943323

   Open questions at the time

   • Endogenous physiological substrates were unknown
   • Relative contribution of each MAPK pathway to MK3 activation in vivo was undefined
   • Functional redundancy with paralog MK2 was not addressed
2. 2000 Medium

   Discovery that MK3 phosphorylates and represses the bHLH transcription factor E47 provided the first evidence linking MK3 to transcriptional regulation.

   Evidence Co-immunoprecipitation, in vitro kinase assay, E-box reporter assay

   PMID:10781029

   Open questions at the time

   • Phosphorylation sites on E47 were not mapped
   • In vivo relevance of E47 repression by MK3 was not tested
   • Single-lab finding without independent replication
3. 2004 High

   Establishing MK3 as a kinase that phosphorylates Bmi1 and dissociates Polycomb complexes from chromatin revealed a direct link between MAPK signaling and epigenetic gene regulation at the INK4A locus.

   Evidence Yeast two-hybrid, co-IP, in vitro kinase assay, chromatin fractionation, reporter gene assay

   PMID:15563468

   Open questions at the time

   • Specific Bmi1 phosphorylation sites mediating chromatin dissociation were not fully characterized
   • Whether MK3-Bmi1 axis operates in primary cells and tissues was untested
4. 2006 High

   Generation of MK2/MK3 double-knockout mice demonstrated that MK3 cooperates with MK2 in TNF biosynthesis and mutual stabilization of p38, defining their partially redundant physiological roles in innate immunity.

   Evidence MK3-KO and MK2/MK3-DKO mice, LPS stimulation, TNF ELISA, immunoblotting, ectopic rescue

   PMID:17030606

   Open questions at the time

   • MK3-specific substrates versus shared MK2/MK3 substrates were not distinguished
   • Tissue-specific functions of MK3 independent of MK2 remained unclear
5. 2010 High

   Identification of an MK3 splice variant (MK3.2) that lacks nuclear localization signals and undergoes p38-dependent proteasomal degradation revealed isoform-specific regulation of MK3 activity and localization.

   Evidence cDNA cloning, live-cell imaging, mutagenesis (T203A), SB203580 and MG132 inhibitors, in vitro kinase assay

   PMID:20570725

   Open questions at the time

   • Physiological relevance of MK3.2 isoform in intact tissue was not demonstrated
   • Whether MK3.2 has distinct substrates or acts as a dominant negative was unknown
6. 2011 Medium

   Demonstrating that MK3 negatively regulates IFNβ and NF-κB signaling by stabilizing IκBβ—an effect normally counteracted by MK2—established opposing regulatory roles for the two paralogs in macrophage inflammatory responses.

   Evidence MK2-KO and MK2/3-DKO macrophages, nuclear translocation assays, siRNA, immunoblotting, cytokine ELISA

   PMID:21586572

   Open questions at the time

   • Whether MK3 directly phosphorylates IκBβ or acts indirectly was not resolved
   • Mechanism by which MK2 prevents MK3 inhibitory function was unclear
7. 2015 High

   Identification of Beclin 1 S90 as a direct MK2/MK3 phosphorylation site essential for starvation-induced autophagy and tumor suppression linked MAPK-activated protein kinases to autophagic regulation, with BCL2 acting as an epistatic inhibitor of this phosphorylation.

   Evidence In vitro kinase assay, S90A mutagenesis, MK2/MK3-DKO cells and mice, autophagy flux assays, BCL2 overexpression

   PMID:25693418

   Open questions at the time

   • Relative contributions of MK2 versus MK3 to Beclin 1 S90 phosphorylation in vivo were not separated
   • Downstream mechanism linking pS90-Beclin 1 to autophagosome formation was not defined
8. 2015 Medium

   Extending the Polycomb connection, MK3 overexpression was shown to reduce EZH2 levels, deplete H3K27me3 at CDKN2A, and induce senescence—rescued by Bmi1 but not EZH2—positioning Bmi1 as the critical downstream effector of MK3 in PRC-mediated gene silencing.

   Evidence ChIP, immunoblotting, flow cytometry, senescence assays, Bmi1 rescue in diploid fibroblasts

   PMID:25853770

   Open questions at the time

   • How MK3-dependent Bmi1 phosphorylation leads to EZH2 protein loss was not mechanistically explained
   • In vivo relevance of MK3-driven senescence was not tested
9. 2016 Medium

   Linking a heterozygous MAPKAPK3 missense mutation (L173P) to retinal dystrophy established the first Mendelian disease association for this kinase, with the mutation causing nuclear-to-cytoplasmic mislocalization and cytokinesis defects.

   Evidence Whole-exome sequencing, ectopic expression with fluorescence microscopy in HEK cells, Mapkapk3-KO mouse retinal histology

   PMID:26744326

   Open questions at the time

   • Only a single family was reported; independent replication in additional pedigrees is lacking
   • Mechanism linking MK3 mislocalization to photoreceptor degeneration was not defined
   • Whether kinase activity is lost or mislocalized activity is pathogenic was not distinguished
10. 2019 Medium

    Transcriptome-wide analysis in MK2/MK3-DKO macrophages confirmed MK3's role in restraining NF-κB via IκBβ stabilization and revealed distinct cooperative regulation of LPS-responsive genes including IL-10, IL-19, CXCL2, and IL-4Rα.

    Evidence RNA-seq of BMDM from MK2-KO and MK2/3-DKO mice, nuclear translocation assays, immunoblotting

    PMID:31363109

    Open questions at the time

    • Direct versus indirect transcriptional targets of MK3 were not distinguished
    • Whether MK3 kinase activity is required for IκBβ stabilization was not tested with kinase-dead mutants

• Key unresolved questions include whether MK3 directly phosphorylates IκBβ, the structural basis of isoform-specific p38 activation and proteasomal targeting, the full in vivo substrate spectrum distinguishing MK3 from MK2, and the pathogenic mechanism of MAPKAPK3 mutations in retinal dystrophy.
• No in vitro kinase assay demonstrating direct IκBβ phosphorylation by MK3
• Structural basis for MK3.2 isoform instability and differential p38 phosphorylation is unknown
• Independent replication of the MAPKAPK3-retinal dystrophy association is absent
• Bax phosphorylation by MK3 awaits reconstitution with purified components and site mapping